Coronavirus: Oxford vaccine triggers immune response. 2020. (accessed 21 July 2020)

New clinical trial platform launched to accelerate COVID-19 treatments. 2020. (accessed 9 July 2020)

National Institute for Health and Care Excellence. Coronavirus (COVID-19). 2020. (accessed 13 July 2020)

National Institute for Health Research. First drug to reduce mortality in hospitalised patients with respiratory complications of COVID-19 found. 2020. (accessed 19 June 2020)

Everything you need to know about the COVID-19 therapy trials. 2020a. (accessed 9 July 2020)

Richard Hobbs: ‘This trial has been a monumental task’. 2020b. (accessed 15 July 2020)

World Health Organization. Draft landscape of COVID-19 candidate vaccines. 2020. (accessed 15 July 2020)

Treatments for COVID-19: where are we now?

02 August 2020
Volume 25 · Issue 8

Clinicians and scientists in the UK are leading the fight against COVID-19 as an innovative platform has been launched by the University of Liverpool, the Liverpool School of Tropical Medicine and the Southampton Clinical Trials Unit. This news follows last month's news that the largest randomised controlled clinical trial for a COVID-19 treatment, funded by the UK's National Institute for Health Research (NIHR), led to the discovery of dexamethasone as the first drug to improve survival rates (NIHR, 2020).

The new drug-testing platform is called AGILE and was developed by infectious disease clinicians, clinical and preclinical pharmacologists, clinical trials specialists, as well as statisticians. Its mission is to test new drugs for COVID-19 from all over the world at an accelerated pace, identifying those compounds that can most effectively fight the virus with patient safety being the top priority, according to the Medicines and Healthcare products Regulatory Agency (MHRA) (McKee, 2020).

Register now to continue reading

Thank you for visiting Community Nursing and reading some of our peer-reviewed resources for district and community nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month